Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Pain assessment and factors influencing pain during bone marrow aspiration: A prospective study.

Gendron N, Zia Chahabi S, Poenou G, Rivet N, Belleville-Rolland T, Lemaire P, Escuret A, Ciaudo M, Curis E, Gaussem P, Siguret V, Darnige L.

PLoS One. 2019 Aug 29;14(8):e0221534. doi: 10.1371/journal.pone.0221534. eCollection 2019.

2.

Evaluation of commonly used tests to measure the effect of single-dose aspirin on mouse hemostasis.

Decouture B, Leuci A, Dizier B, Belleville-Rolland T, Mansour A, Martin F, Pidard D, Gaussem P, Bachelot-Loza C.

Prostaglandins Leukot Essent Fatty Acids. 2019 Oct;149:46-51. doi: 10.1016/j.plefa.2019.08.002. Epub 2019 Aug 8.

PMID:
31442897
3.

Successful Use of Recombinant Activated Factor VII to Reverse Ticagrelor-Induced Bleeding Risk: A Case Report.

Godier A, Dupont M, Desilles JP, Le Guerinel C, Taylor G, Perrin M, Martin AC, Gaussem P.

TH Open. 2018 Sep 27;2(3):e346-e349. doi: 10.1055/s-0038-1672211. eCollection 2018 Jul.

4.

Rivaroxaban pharmacodynamics in healthy volunteers evaluated with thrombin generation and the active protein C system: Modeling and assessing interindividual variability.

Siguret V, Abdoul J, Delavenne X, Curis E, Carlo A, Blanchard A, Salem JE, Gaussem P, Funck-Brentano C, Azizi M, Mismetti P, Loriot MA, Lecompte T, Gouin-Thibault I.

J Thromb Haemost. 2019 Oct;17(10):1670-1682. doi: 10.1111/jth.14541. Epub 2019 Jul 9.

PMID:
31215111
5.

Murine platelet production is suppressed by S1P release in the hematopoietic niche, not facilitated by blood S1P sensing.

Niazi H, Zoghdani N, Couty L, Leuci A, Nitzsche A, Allende ML, Mariko B, Ishaq R, Aslan Y, Becker PH, Gazit SL, Poirault-Chassac S, Decouture B, Baudrie V, De Candia E, Kono M, Benarab A, Gaussem P, Tharaux PL, Chun J, Provot S, Debili N, Therond P, Proia RL, Bachelot-Loza C, Camerer E.

Blood Adv. 2019 Jun 11;3(11):1702-1713. doi: 10.1182/bloodadvances.2019031948.

6.

Human Endothelial Colony Forming Cells Express Intracellular CD133 that Modulates their Vasculogenic Properties.

Rossi E, Poirault-Chassac S, Bieche I, Chocron R, Schnitzler A, Lokajczyk A, Bourdoncle P, Dizier B, Bacha NC, Gendron N, Blandinieres A, Guerin CL, Gaussem P, Smadja DM.

Stem Cell Rev Rep. 2019 Aug;15(4):590-600. doi: 10.1007/s12015-019-09881-8.

PMID:
30879244
7.

Interleukin-8 release by endothelial colony-forming cells isolated from idiopathic pulmonary fibrosis patients might contribute to their pathogenicity.

Blandinières A, Gendron N, Bacha N, Bièche I, Chocron R, Nunes H, Nevo N, Rossi E, Crestani B, Lecourt S, Chevret S, Lokajczyk A, Mignon V, Kisaoglu A, Juvin K, Bertil S, Valeyre D, Cras A, Gaussem P, Israël-Biet D, Smadja DM.

Angiogenesis. 2019 May;22(2):325-339. doi: 10.1007/s10456-018-09659-5. Epub 2019 Jan 3.

PMID:
30607696
8.

Treprostinil treatment decreases circulating platelet microvesicles and their procoagulant activity in pediatric pulmonary hypertension.

Bacha NC, Levy M, Guerin CL, Le Bonniec B, Harroche A, Szezepanski I, Renard JM, Gaussem P, Israel-Biet D, Boulanger CM, Smadja DM.

Pediatr Pulmonol. 2019 Jan;54(1):66-72. doi: 10.1002/ppul.24190. Epub 2018 Nov 28.

PMID:
30485728
9.

Modified ROTEM for the detection of rivaroxaban and apixaban anticoagulant activity in whole blood: A diagnostic test study.

Pailleret C, Jourdi G, Siguret V, Gouin-Thibault I, Gandrille S, Stepanian A, Curis E, Golmard JL, Gaussem P, Le Bonniec B, Samama CM.

Eur J Anaesthesiol. 2019 Jun;36(6):449-456. doi: 10.1097/EJA.0000000000000903.

PMID:
30308522
10.

Endothelial Colony-Forming Cells Do Not Participate to Fibrogenesis in a Bleomycin-Induced Pulmonary Fibrosis Model in Nude Mice.

Blandinières A, Gille T, Sadoine J, Bièche I, Slimani L, Dizier B, Gaussem P, Chaussain C, Planes C, Dorfmüller P, Israël-Biet D, Smadja DM.

Stem Cell Rev Rep. 2018 Dec;14(6):812-822. doi: 10.1007/s12015-018-9846-5.

PMID:
30267203
11.

FXa-α2-Macroglobulin Complex Neutralizes Direct Oral Anticoagulants Targeting FXa In Vitro and In Vivo.

Jourdi G, Gouin-Thibault I, Siguret V, Gandrille S, Gaussem P, Le Bonniec B.

Thromb Haemost. 2018 Sep;118(9):1535-1544. doi: 10.1055/s-0038-1667014. Epub 2018 Aug 2.

PMID:
30071567
12.

Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a month.

Eyraud D, Suner L, Dupont A, Bachelot-Loza C, Smadja DM, Helley D, Bertil S, Gostian O, Szymezak J, Loncar Y, Puybasset L, Lebray P, Vezinet C, Vaillant JC, Granger B, Gaussem P.

PLoS One. 2018 Aug 2;13(8):e0200364. doi: 10.1371/journal.pone.0200364. eCollection 2018.

13.

Erratum to "Thrombin generation test: A reliable tool to evaluate the pharmacodynamics of vitamin K antagonist rodenticides in rats" [Pestic. Biochem. Physiol. 146 (2018) 19-24].

Jourdi G, Lefèbvre S, Le Bonniec B, Curis E, Gaussem P, Lattard V, Siguret V.

Pestic Biochem Physiol. 2018 Jul;149:149. doi: 10.1016/j.pestbp.2018.05.003. Epub 2018 May 16. No abstract available.

PMID:
30033011
14.

Beta-1,4-galactosyltransferase 2 c.909C>T gene variant is predictive of on-clopidogrel platelet reactivity.

Pallet N, Belleville-Rolland T, Savalle A, Lejeune M, Mauge L, Bertil S, Loriot MA, Gaussem P.

Pharmacogenomics. 2018 Aug 1;19(12):937-945. doi: 10.2217/pgs-2018-0057. Epub 2018 Jul 18.

PMID:
30020015
15.

CD34+ Hematopoietic Stem Cell Count Is Predictive of Vascular Event Occurrence in Children with Sickle Cell Disease.

Kossorotoff M, De Montalembert M, Brousse V, Lasne D, Curis E, Smadja DM, Lacroix R, Bertil S, Masson E, Desguerre I, Bonnet D, Gaussem P.

Stem Cell Rev Rep. 2018 Oct;14(5):694-701. doi: 10.1007/s12015-018-9835-8.

PMID:
29931411
16.

Evidence that MRP4 is Only Partly Involved in S1P Secretion during Platelet Activation.

Decouture B, Becker PH, Therond P, Gaussem P, Bachelot-Loza C.

Thromb Haemost. 2018 Jun;118(6):1116-1118. doi: 10.1055/s-0038-1641754. Epub 2018 Apr 18. No abstract available.

PMID:
29669387
18.

Usefulness of initial plasma dabigatran concentration to predict rebound after reversal.

Gendron N, Gay J, Lemoine M, Gaussem P, Lillo-Le-Louet A, Smadja DM.

Haematologica. 2018 May;103(5):e226-e229. doi: 10.3324/haematol.2017.183400. Epub 2018 Feb 22. No abstract available.

19.

Reduced endothelial thioredoxin-interacting protein protects arteries from damage induced by metabolic stress in vivo.

Bedarida T, Domingues A, Baron S, Ferreira C, Vibert F, Cottart CH, Paul JL, Escriou V, Bigey P, Gaussem P, Leguillier T, Nivet-Antoine V.

FASEB J. 2018 Jun;32(6):3108-3118. doi: 10.1096/fj.201700856RRR. Epub 2018 Jan 17.

PMID:
29401599
20.

Endothelial Microparticles are Associated to Pathogenesis of Idiopathic Pulmonary Fibrosis.

Bacha NC, Blandinieres A, Rossi E, Gendron N, Nevo N, Lecourt S, Guerin CL, Renard JM, Gaussem P, Angles-Cano E, Boulanger CM, Israel-Biet D, Smadja DM.

Stem Cell Rev Rep. 2018 Apr;14(2):223-235. doi: 10.1007/s12015-017-9778-5.

PMID:
29101610
21.

Human endoglin as a potential new partner involved in platelet-endothelium interactions.

Rossi E, Pericacho M, Bachelot-Loza C, Pidard D, Gaussem P, Poirault-Chassac S, Blanco FJ, Langa C, González-Manchón C, Novoa JML, Smadja DM, Bernabeu C.

Cell Mol Life Sci. 2018 Apr;75(7):1269-1284. doi: 10.1007/s00018-017-2694-7. Epub 2017 Oct 28.

22.

Pulsed cavitational therapy using high-frequency ultrasound for the treatment of deep vein thrombosis in an in vitro model of human blood clot.

Goudot G, Mirault T, Arnal B, Boisson-Vidal C, Le Bonniec B, Gaussem P, Galloula A, Tanter M, Messas E, Pernot M.

Phys Med Biol. 2017 Nov 21;62(24):9282-9294. doi: 10.1088/1361-6560/aa9506.

PMID:
29053109
23.

Egfl7 Represses the Vasculogenic Potential of Human Endothelial Progenitor Cells.

d'Audigier C, Susen S, Blandinieres A, Mattot V, Saubamea B, Rossi E, Nevo N, Lecourt S, Guerin CL, Dizier B, Gendron N, Caetano B, Gaussem P, Soncin F, Smadja DM.

Stem Cell Rev Rep. 2018 Feb;14(1):82-91. doi: 10.1007/s12015-017-9775-8.

PMID:
28980146
24.

Hemolytic anemia, iron deficiency and personal history of deep vein thrombosis: consider paroxysmal nocturnal hemoglobinuria.

Gendron N, Arlet JB, Gaussem P, Radford-Weiss I, Dupeux S, Rosain J, La Tour RP, Darnige L.

Ann Biol Clin (Paris). 2017 Oct 1;75(5):580-588. doi: 10.1684/abc.2017.1277.

PMID:
28958970
25.

The Carmat Bioprosthetic Total Artificial Heart Is Associated With Early Hemostatic Recovery and no Acquired von Willebrand Syndrome in Calves.

Smadja DM, Susen S, Rauch A, Cholley B, Latrémouille C, Duveau D, Zilberstein L, Méléard D, Boughenou MF, Belle EV, Gaussem P, Capel A, Jansen P, Carpentier A.

J Cardiothorac Vasc Anesth. 2017 Oct;31(5):1595-1602. doi: 10.1053/j.jvca.2017.02.184. Epub 2017 Mar 1.

PMID:
28648774
26.

[Antiplatelet agents and transfusion].

Gaussem P, Martin AC, Belleville-Rolland T, Helley D, Bachelot-Loza C, Godier A.

Transfus Clin Biol. 2017 Sep;24(3):160-165. doi: 10.1016/j.tracli.2017.05.014. Epub 2017 Jun 20. Review. French.

PMID:
28645644
27.

[The role of extracorporeal removal of CO2 (ECCO2R) in the management of respiratory diseases].

Diehl JL, Boisramé-Helms J, Chardon-Couteau A, Commereuc M, Augy JL, Sokoloff A, Rivet N, Gaussem P, Smadja DM, Aissaoui N.

Rev Mal Respir. 2017 Jun;34(6):598-606. doi: 10.1016/j.rmr.2017.02.003. Epub 2017 May 12. Review. French.

PMID:
28506729
28.

Ticagrelor reversal: in vitro assessment of four haemostatic agents.

Calmette L, Martin AC, Le Bonniec B, Zlotnik D, Gouin-Thibault I, Bachelot-Loza C, Gaussem P, Godier A.

J Clin Pathol. 2017 Sep;70(9):733-739. doi: 10.1136/jclinpath-2016-204117. Epub 2017 Feb 3.

PMID:
28159767
29.

Prospective observational study of the effect of dual antiplatelet therapy with tranexamic acid treatment on platelet function and bleeding after cardiac surgery.

Amour J, Garnier M, Szymezak J, Le Manach Y, Helley D, Bertil S, Ouattara A, Riou B, Gaussem P.

Br J Anaesth. 2016 Dec;117(6):749-757.

30.

Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin.

Gouin-Thibault I, Delavenne X, Blanchard A, Siguret V, Salem JE, Narjoz C, Gaussem P, Beaune P, Funck-Brentano C, Azizi M, Mismetti P, Loriot MA.

J Thromb Haemost. 2017 Feb;15(2):273-283. doi: 10.1111/jth.13577. Epub 2017 Feb 6.

31.

Impaired thromboxane receptor dimerization reduces signaling efficiency: A potential mechanism for reduced platelet function in vivo.

Capra V, Mauri M, Guzzi F, Busnelli M, Accomazzo MR, Gaussem P, Nisar SP, Mundell SJ, Parenti M, Rovati GE.

Biochem Pharmacol. 2017 Jan 15;124:43-56. doi: 10.1016/j.bcp.2016.11.010. Epub 2016 Nov 11.

32.

Platelet and Erythrocyte Sources of S1P Are Redundant for Vascular Development and Homeostasis, but Both Rendered Essential After Plasma S1P Depletion in Anaphylactic Shock.

Gazit SL, Mariko B, Thérond P, Decouture B, Xiong Y, Couty L, Bonnin P, Baudrie V, Le Gall SM, Dizier B, Zoghdani N, Ransinan J, Hamilton JR, Gaussem P, Tharaux PL, Chun J, Coughlin SR, Bachelot-Loza C, Hla T, Ho-Tin-Noé B, Camerer E.

Circ Res. 2016 Sep 30;119(8):e110-26. doi: 10.1161/CIRCRESAHA.116.308929. Epub 2016 Aug 31.

33.

MRP4 (ABCC4) as a potential pharmacologic target for cardiovascular disease.

Belleville-Rolland T, Sassi Y, Decouture B, Dreano E, Hulot JS, Gaussem P, Bachelot-Loza C.

Pharmacol Res. 2016 May;107:381-389. doi: 10.1016/j.phrs.2016.04.002. Epub 2016 Apr 5. Review.

PMID:
27063943
34.

Endoglin regulates mural cell adhesion in the circulatory system.

Rossi E, Smadja DM, Boscolo E, Langa C, Arevalo MA, Pericacho M, Gamella-Pozuelo L, Kauskot A, Botella LM, Gaussem P, Bischoff J, Lopez-Novoa JM, Bernabeu C.

Cell Mol Life Sci. 2016 Apr;73(8):1715-39. doi: 10.1007/s00018-015-2099-4. Epub 2015 Dec 8.

35.

The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation: An in-vitro study.

Martin AC, Berndt C, Calmette L, Philip I, Decouture B, Gaussem P, Gouin-Thibault I, Samama CM, Bachelot-Loza C, Godier A.

Eur J Anaesthesiol. 2016 May;33(5):361-7. doi: 10.1097/EJA.0000000000000348.

PMID:
26351831
36.

Impaired platelet activation and cAMP homeostasis in MRP4-deficient mice.

Decouture B, Dreano E, Belleville-Rolland T, Kuci O, Dizier B, Bazaa A, Coqueran B, Lompre AM, Denis CV, Hulot JS, Bachelot-Loza C, Gaussem P.

Blood. 2015 Oct 8;126(15):1823-30. doi: 10.1182/blood-2015-02-631044. Epub 2015 Aug 27.

37.

Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells.

Smadja DM, Levy M, Huang L, Rossi E, Blandinières A, Israel-Biet D, Gaussem P, Bischoff J.

Thromb Haemost. 2015 Oct;114(4):735-47. doi: 10.1160/TH14-11-0907. Epub 2015 Jun 11.

38.

Thrombin receptor PAR-1 activation on endothelial progenitor cells enhances chemotaxis-associated genes expression and leukocyte recruitment by a COX-2-dependent mechanism.

d'Audigier C, Cochain C, Rossi E, Guérin CL, Bièche I, Blandinières A, Marsac B, Silvestre JS, Gaussem P, Smadja DM.

Angiogenesis. 2015 Jul;18(3):347-59. doi: 10.1007/s10456-015-9471-8. Epub 2015 May 31.

PMID:
26026674
39.

Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxaban.

Jourdi G, Siguret V, Martin AC, Golmard JL, Godier A, Samama CM, Gaussem P, Gouin-Thibault I, Le Bonniec B.

Thromb Haemost. 2015 Jul;114(1):78-86. doi: 10.1160/TH14-10-0877. Epub 2015 Mar 12.

PMID:
25761505
40.

Multimodal assessment of non-specific hemostatic agents for apixaban reversal.

Martin AC, Gouin-Thibault I, Siguret V, Mordohay A, Samama CM, Gaussem P, Le Bonniec B, Godier A.

J Thromb Haemost. 2015 Mar;13(3):426-36. doi: 10.1111/jth.12830. Epub 2015 Feb 5.

41.

Bone-marrow-derived very small embryonic-like stem cells in patients with critical leg ischaemia: evidence of vasculogenic potential.

Guerin CL, Loyer X, Vilar J, Cras A, Mirault T, Gaussem P, Silvestre JS, Smadja DM.

Thromb Haemost. 2015 May;113(5):1084-94. doi: 10.1160/TH14-09-0748. Epub 2015 Jan 22.

PMID:
25608764
42.

Inefficacy of platelet transfusion to reverse ticagrelor.

Godier A, Taylor G, Gaussem P.

N Engl J Med. 2015 Jan 8;372(2):196-7. doi: 10.1056/NEJMc1409373. No abstract available.

PMID:
25564918
43.

Evaluation of endothelial damage in sepsis-related ARDS using circulating endothelial cells.

Moussa MD, Santonocito C, Fagnoul D, Donadello K, Pradier O, Gaussem P, De Backer D, Vincent JL.

Intensive Care Med. 2015 Feb;41(2):231-8. doi: 10.1007/s00134-014-3589-9. Epub 2014 Dec 16.

PMID:
25510299
44.

[Thrombopathy induced by selective serotonin reuptake inhibitors: a case report].

Ben Said M, Amar L, Smadja D, Rivet N, Bertil S, Fischer AM, Helley D, Gaussem P.

Ann Biol Clin (Paris). 2014 Sep-Oct;72(5):607-11. doi: 10.1684/abc.2014.0997. French.

45.

Increase in both angiogenic and angiostatic mediators in patients with idiopathic pulmonary fibrosis.

Smadja DM, Nunes H, Juvin K, Bertil S, Valeyre D, Gaussem P, Israel-Biet D.

Pathol Biol (Paris). 2014 Dec;62(6):391-4. doi: 10.1016/j.patbio.2014.07.006. Epub 2014 Sep 16.

PMID:
25239280
46.

Cerebral haemorrhagic risk in children with sickle-cell disease.

Kossorotoff M, Brousse V, Grevent D, Naggara O, Brunelle F, Blauwblomme T, Gaussem P, Desguerre I, De Montalembert M.

Dev Med Child Neurol. 2015 Feb;57(2):187-93. doi: 10.1111/dmcn.12571. Epub 2014 Aug 30.

47.

Impact of aspirin and clopidogrel interruption on platelet function in patients undergoing major vascular surgery.

Le Manach Y, Kahn D, Bachelot-Loza C, Le Sache F, Smadja DM, Remones V, Loriot MA, Coriat P, Gaussem P.

PLoS One. 2014 Aug 20;9(8):e104491. doi: 10.1371/journal.pone.0104491. eCollection 2014.

48.

Cooperation between human fibrocytes and endothelial colony-forming cells increases angiogenesis via the CXCR4 pathway.

Smadja DM, Dorfmüller P, Guerin CL, Bieche I, Badoual C, Boscolo E, Kambouchner M, Cazes A, Mercier O, Humbert M, Gaussem P, Bischoff J, Israël-Biet D.

Thromb Haemost. 2014 Nov;112(5):1002-13. doi: 10.1160/TH13-08-0711. Epub 2014 Aug 7.

49.

Imbalanced coagulation profile as a biomarker of migraine in children with sickle cell: Is this a link with cerebral ischemia?

Kossorotoff M, Lasne D, Brousse V, Desguerre I, de Montalembert M, Gaussem P.

J Pediatr. 2014 Sep;165(3):645-6. doi: 10.1016/j.jpeds.2014.05.052. Epub 2014 Jul 9. No abstract available.

PMID:
25015573
50.

[Management of vitamin K antagonists in the elderly].

Belleville T, Pautas É, Gaussem P, Siguret V.

Ann Biol Clin (Paris). 2014 Mar-Apr;72(2):185-92. doi: 10.1684/abc.2014.0933. Review. French.

Supplemental Content

Loading ...
Support Center